EUVIMEDEUVIMED entdecken
Crossref

Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth

Faith Lindsay Mart iD, Iris Gutmark-Little iD, Tara Streich-Tilles, Andrew T Trout iD, Jane Khoury iD, Katherine Bowers, Lori Casnellie iD, Philippe Backeljauw iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Faith Lindsay Mart und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3026, USA. Hauptthemen laut MEDLINE: Turner Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Endocrine Fellows Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Most individuals with Turner syndrome (TS) require estrogen for pubertal induction. Current estrogen dosing guidelines are based on expert consensus opinion.

Objective

Evaluate whether current international guidelines for estrogen dosing during pubertal induction of individuals with TS result in normal uterine growth. We hypothesized that uterine size in individuals with TS who reached adult estrogen dosing is smaller than in mature females without TS.

Methods

Cross-sectional study of patients with TS at the Cincinnati Center for Pediatric and Adult Turner Syndrome Care. Twenty-nine individuals (age 15-26 years) with primary ovarian insufficiency who reached adult estrogen dosing (100 µg of transdermal or 2 mg of oral 17β-estradiol) were included. Comparison of uterine measurements with a published sample of 292 age-appropriate (age 15-20 years) controls without TS. Uterine length, volume, and fundal–cervical ratio (FCR) were measured. Clinical information (karyotype, Tanner staging for breast development, laboratory data) was extracted from an existing institutional patient registry.

Results

There was no evidence of compromise of the uterine size/configuration in the TS cohort compared with the controls; in fact, uterine length, mean 7.7 cm (±1.3) vs 7.2 cm (±1.0) (P = .03), and volume, mean 60.6 cm3 (±26.6) vs 50.5 cm3 (±20.5) (P = .02), were both larger in individuals with TS.

Conclusion

Current international guidelines for hormone replacement using 17β-estradiol in individuals with TS appear adequate to allow for normal uterine growth by the end of pubertal induction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Turner SyndromeFemaleAdultChildHumansAdolescentYoung AdultCross-Sectional StudiesEstrogensEstradiolHormone Replacement Therapy

Stichwörter der Autor:innen

17β-estradiolTurner syndromepubertal inductionuterine size

Substanzen

EstrogensEstradiol

Autor:innen und Institutionen

  • Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3026, USA.
  • Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
  • Division of Pediatric and Adolescent Gynecology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3026, USA.
  • Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
  • Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3026, USA.
  • Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3026, USA.

ORCID-Profile: Faith Lindsay Mart, Iris Gutmark-Little, Andrew T Trout, Jane Khoury, Lori Casnellie, Philippe Backeljauw

Förderung

  • Endocrine Fellows Foundation

Zitieren

APA

Lindsay Mart, F., Gutmark-Little, I., Streich-Tilles, T., Trout, A. T., Khoury, J., Bowers, K., Casnellie, L., & Backeljauw, P. (2024). Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad649

Vancouver

Lindsay Mart F, Gutmark-Little I, Streich-Tilles T, Trout AT, Khoury J, Bowers K, et al. Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad649

BibTeX
@article{LindsayMart2024,
  author = {Lindsay Mart, Faith and Gutmark-Little, Iris and Streich-Tilles, Tara and Trout, Andrew T and Khoury, Jane and Bowers, Katherine and Casnellie, Lori and Backeljauw, Philippe},
  title = {Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad649}
}
Kostenlos starten →